http://www.hcplive.com/publications/internal-medicine-world-report/2014/September-2014/Older-Folks-and-Influenza-High-Dose-Vaccine-24-More-Effective
Thanks
Rob
This email was sent from a mobile device with an annoyingly small keyboard, apologies for any typos
hVIVO is the new name of Retroscreen Virology! (from 15 April 2015). hVIVO is a rapidly growing UK life sciences company pioneering a technology platform which uses human challenge models of disease involving healthy volunteers to study new drugs and investigate disease in a safe, controlled, clinical environment. Our belief is that the best way to understand human disease is by studying it in humans, not laboratory models.
No comments:
Post a Comment